Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products

SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...

The NYSE Welcomes vVARDIS as a Publicly Listed Company

Cision PR Newswire

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture...
Cision PR Newswire

Innovent Announces Seven Innovative Products Including Mazdutide and PECONDLE® Successfully Included in the 2026 National Reimbursement Drug List

PALO ALTO, Calif. and SUZHOU, China, Nov. 14, 2026 /PRNewswire/ -- Innovent Biologics, Inc....
Cision PR Newswire

WeFetch AI Corp. Is the New Name of GreenCore Solutions Corp.

gtinfetch.ai, WeFetch.ai's lead product, removes the guess from artificial intelligence (AI) shopping: the right...
Cision PR Newswire

MVGX Releases 2024 Sustainability and Impact Report, Achieves “Gold” Decarbonisation Rating

SINGAPORE, Sept. 15, 2025 /PRNewswire/ -- MVGX Tech Pte. Ltd. ("MVGX"), a leader in sustainability compliance technology, today announced two landmark milestones: the release...

SPTel and iWOW Technology Partner to Expand Wireless Alert Alarm System Initiative across Singapore

SINGAPORE, Sept. 15, 2025 /PRNewswire/ -- SPTel and iWOW Technology (iWOW) today announced their partnership to support the expansion of the wireless Alert Alarm...

EverBridge Group and Cosmotec Forge Landmark Partnership

SHANGHAI, Sept. 15, 2025 /PRNewswire/ -- EverBridge Group announced an Exclusive Commercialization Partnership with Cosmotec Inc. (a Wholly Owned Subsidiary of M3, Inc.; TSE:...

Lion TCR Achieves Triple FDA Milestones with IND Clearance for Chronic Hepatitis B Following Earlier Fast Track and Orphan Drug Designations

SINGAPORE...

Phrontline Biopharma Announces First Patient Dosed in Phase 1 Clinical Trial of TJ101

SHANGHAI and SUZHOU, China, Sept. 15, 2025 /PRNewswire/ -- Phrontline Biopharma, a clinical-stage biotechnology company advancing a new generation of Antibody-Drug Conjugates (ADCs), today...

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts at the 18th International lgAN Symposium

7 new NEFECON® real-world evidence abstracts will be presented at the 18th International lgA Nephropathy Symposium (IIgANN 2025). The newly released results,...
1...2,7482,7492,750...4,530Page 2,749 of 4,530